Results 21 to 30 of about 7,985,327 (252)

Analysis on complete pathological response and estimated survival among breast cancer patients undergoing neoadjuvant chemotherapy in a private institution in the state of Rio de Janeiro

, 2021
Objective: Breast cancer is the most common malignancy among women, both in developed and in developing countries. Indications for neoadjuvant treatment have been expanded so that pathological responses can be evaluated.
Letícia Morais C. O. Sermoud, Dante Pagnoncelli, Gustavo Buscacio, Luiz Henrique Araujo, Lilian Campos Lerner, Thamirez de Almeida Vieira Ferreira, Maria de Fátima Dias Gaui   +6 more
core   +1 more source

Pathological complete response of locally advanced colon cancer after preoperative radiotherapy: a case report and narrative review of the literature

Surgical Case Reports, 2018
Background The oncological effectiveness of preoperative radiotherapy for locally advanced colon cancer is unclear. We report a case of pathological complete response in a patient with locally advanced ascending colon cancer after preoperative ...
Sho Sekiya, Kiyotaka Imamura, Shintaro Takeuchi, Koichi Teramura, Yusuke Watanabe, Eiji Tamoto, Minoru Takada, Yoshihiro Kinoshita, Yoshiyasu Anbo, Fumitaka Nakamura, Nobuichi Kashimura, Hiroko Noguchi, Katsutoshi Miura, Satoshi Hirano   +13 more
doaj   +1 more source

PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnostic histopathology biopsies with deep learning

Breast Cancer Research, 2023
Background Invasive breast cancer patients are increasingly being treated with neoadjuvant chemotherapy; however, only a fraction of the patients respond to it completely.
Witali Aswolinskiy, Enrico Munari, Hugo M. Horlings, Lennart Mulder, Giuseppe Bogina, Joyce Sanders, Yat-Hee Liu, Alexandra W. van den Belt-Dusebout, Leslie Tessier, Maschenka Balkenhol, Michelle Stegeman, Jeffrey Hoven, Jelle Wesseling, Jeroen van der Laak, Esther H. Lips, Francesco Ciompi   +15 more
doaj   +1 more source

Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast [PDF]

, 2008
Introduction To investigate the predictive value of clinical and biological markers for a pathological complete remission after a preoperative dose-dense regimen of doxorubicin and docetaxel, with or without tamoxifen, in primary operable breast cancer ...
Sinn, Hans-Peter, Sibylle Loibl, Jens-Uwe Blohmer, Jörn Hilfrich, Eidtmann, Holger, Jackisch, Christian, Minckwitz, Gunter von, Elisabeth Merkle, Hilfrich, Jörn, Caputo, Angelika, Angelika Caputo, Merkle, Elisabeth, Dan Costa, Serban, Blohmer, Jens-Uwe, Gunter von Minckwitz, Raab, Günter, German Breast Group (GBG), [Study group], Christian Jackisch, Hans-Peter Sinn, Serban D Costa, Holger Eidtmann, Loibl, Sibylle, Manfred Kaufmann, von Minckwitz, Gunter, null null, Günter Raab, Costa, Serban D., Kaufmann, Manfred   +27 more
core   +2 more sources

Clinicopathological Factors Determining the Pathological Response to Neoadjuvant Therapy in HER2 Positive Breast Cancer

Namık Kemal Tıp Dergisi, 2021
Aim:In our study, we aimed to determine the clinicopathological factors affecting the pathological response after neoadjuvant chemotherapy in HER2 positive breast cancer.Materials and Methods:A total of 54 HER2 expression positive cases were included in ...
Abdullah Evren YETİŞİR, Semra PAYDAŞ
doaj   +1 more source

Survival outcomes of locally advanced gastric cancer cases with pathological complete response received neoadjuvant chemotherapy

Precision Medical Sciences, 2021
Objective The aim of this study is to explore the survival situation of locally advanced gastric cancer (GC) patients with pathological complete response (pCR) following neoadjuvant chemotherapy (NAC).
Qing Hu, Jian Wang, Wei‐Guo Xu, Peng Shao, Gang Li   +4 more
doaj   +1 more source

A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer. [PDF]

Oncol Res, 2022
Pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients is related to a favorable prognosis. The identification of early biomarkers predictive of pathological complete response would help to optimize ...
Dalle Fratte C, Mezzalira S, Polesel J, De Mattia E, Palumbo A, Buonadonna A, Palazzari E, De Paoli A, Belluco C, Canzonieri V, Toffoli G, Cecchin E.   +11 more
europepmc   +2 more sources

The effect of tislelizumab on complete and pathological complete response in non-small cell lung cancer: a systematic review and meta-analysis

Frontiers in Oncology
BackgroundImmune checkpoint inhibitors have transformed non-small cell lung cancer (NSCLC) treatment, and while overall survival (OS) and progression-free survival (PFS) are well-established, a comprehensive meta-analysis focusing on complete response ...
Qian Feng, Xiaoxia Yan, Liping Gao, Hui Li, Baik Sarah, Russo Anna, Hongying Jiang   +6 more
doaj   +1 more source

Pathological complete response.

, 2015
Pathological complete response.
Muneharu Konishi (833445), Kazuhiko Yamagami (833443), Daishu Miura (833440), Tomoyuki Kubota (833449), Yoshie Hasegawa (394398), Seung Jin Kim (833442), Takashi Ishikawa (206896), Masaru Miyashita (833444), Masato Suzuki (833447), Yasushi Shigeoka (833446), Jun Horiguchi (833439), Tetsuya Taguchi (833448), Hirokazu Tanino (833438), Norio Kohno (833450), Shintaro Takao (833441), Mitsuhiro Hayashi (679464), Kouhei Akazawa (15187)   +16 more
core   +1 more source

Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial

, 2021
PURPOSE: Intrauterine levonorgestrel (LNG-IUD) is used to treat patients with endometrial adenocarcinoma (EAC) and endometrial hyperplasia with atypia (EHA) but limited evidence is available on its effectiveness.
Oehler, MK, Leung, Y, Cummings, M, Sykes, P, Alizart, M, Garrett, A, Tang, A, Gebski, V, McNally, O, Walker, G, Janda, M, Armes, JE, Robledo, KP, Chen, C, et al.   +14 more
core   +1 more source